2019, Number 4
<< Back Next >>
Rev Mex Pediatr 2019; 86 (4)
Neurodevelopment in children with congenital heart disease at 30 months of age
Mendoza-Sánchez V, Hernández-Negrete LE, Cázarez-Ortiz M, González E, Guido‑Campuzano MA
Language: Spanish
References: 13
Page: 143-146
PDF size: 197.46 Kb.
ABSTRACT
Objective: To describe the neurodevelopmental status of patients with complex congenital heart disease (CCHD), who underwent cardiac surgery in the neonatal period.
Material and methods: Through a longitudinal, observational and retrospective study, we included 14 patients. Neurodevelopment was assessed through the Bayley II child development scale, at the age of 30 months.
Results: The average age at the time of surgery was 19 days. The most frequent heart disease was aortic coarctation (43%). Of the total, 29% had low cognitive development, and 50% with abnormal psychomotor development.
Conclusions: Pediatric patients with CCHD after surgery have a high risk of presenting neurological deficit, predominantly in the psychomotor area.
REFERENCES
Hoffman JI. The global burden of congenital heart disease. Cardiovasc J Afr. 2013; 24(4): 141-145.
Wernovsky G, Licht DJ. Neurodevelopmental outcomes in children with congenital heart disease–what can we impact? Pediatr Crit Care Med. 2016; 17(8 Suppl 1): S232.
Khalil A, Suff N, Thilaganathan B, Hurrell A, Cooper D, Carvalho JS. Brain abnormalities and neurodevelopmental delay in congenital heart disease: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2014; 43(1): 14-24.
Morton PD, Ishibashi N, Jonas RA. Neurodevelopmental abnormalities and congenital heart disease: insights into altered brain maturation. Circ Res. 2017; 120(6): 960-977.
Nattel SN, Adrianzen L, Kessler EC, Andelfinger G, Dehaes M, Côté-Corriveau G et al. Congenital heart disease and neurodevelopment: clinical manifestations, genetics, mechanisms, and implications. Can J Cardiol. 2017; 33(12): 1543-1555.
Massaro AN, El-dib M, Glass P, Aly H. Factors associated with adverse neurodevelopmental outcomes in infants with congenital heart disease. Brain Dev. 2008; 30(7): 437-446.
Lequier L, Joffe AR, Robertson CM, Dinu IA, Wongswadiwat Y, Anton NR et al. Two-year survival, mental, and motor outcomes after cardiac extracorporeal life support at less than five years of age. J Thorac Cardiovasc Surg. 2008; 136(4): 976-983.
Pérez-López J, de la Nuez AG, Martínez-Fuentes MT, Díaz-Herrero A, Sánchez-Caravaca J, Fernández-Rego FJ. Las escalas Bayley BSID-I frente a BSID-II como instrumento de evaluación en atención temprana. Anales de Psicología. 2012; 28(2): 484.
Bayley N. Escalas Bayley de desarrollo infantil. Madrid: TEA. 1977.
Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012; 126(9): 1143-1172.
Snookes SH, Gunn JK, Eldridge BJ, et al. A systematic review of motor and cognitive outcomes after early surgery for congenital heart disease. Pediatrics. 2010;125(4):e818–e827.
Donofrio MT, Massaro AN. Impact of congenital heart disease on brain developmental and developmental outcome. Int J Pediatric. 2010; 2010.
Gerdes M, Flynn T. Clinical assessment of neurobehavioral outcomes in infants and children with congenital heart disease. Progress Pediatr Cardiol. 2010; 29: 97-105.